Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 160.73M | 81.52M | 211.61M | 380.15M | 302.53M |
Gross Profit | 5.94M | 5.44M | 22.49M | 37.76M | 25.08M |
EBITDA | -41.52M | -21.41M | -5.46M | 6.00M | -57.12M |
Net Income | -47.26M | -61.62M | -44.01M | -30.14M | -74.90M |
Balance Sheet | |||||
Total Assets | 227.28M | 250.65M | 309.25M | 426.13M | 416.23M |
Cash, Cash Equivalents and Short-Term Investments | 24.31M | 15.25M | 42.22M | 81.92M | 99.82M |
Total Debt | 5.27M | 13.29M | 1.83M | 1.03M | 2.47M |
Total Liabilities | 75.53M | 69.64M | 63.16M | 81.80M | 68.62M |
Stockholders Equity | 120.34M | 152.58M | 225.84M | 276.39M | 288.45M |
Cash Flow | |||||
Free Cash Flow | -6.25M | -41.70M | 5.80M | -10.84M | -30.84M |
Operating Cash Flow | -1.22M | -39.76M | 6.38M | -10.82M | -30.78M |
Investing Cash Flow | -3.47M | -1.76M | -528.00K | 183.00K | 23.32M |
Financing Cash Flow | 15.87M | 16.89M | -41.40M | -1.45M | -476.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
57 Neutral | HK$14.24B | 5.10 | -5.75% | 5.29% | 9.34% | -42.23% | |
53 Neutral | HK$90.09M | ― | -30.58% | ― | 89.90% | 65.64% | |
51 Neutral | $680.69M | ― | -1.29% | ― | 0.82% | -154.84% | |
45 Neutral | €105.99M | ― | ― | 12.64% | -178.64% | ||
43 Neutral | HK$259.61M | ― | -212.93% | ― | -9.07% | -55.96% | |
40 Underperform | $325.73M | ― | -21.37% | ― | -49.43% | -295.51% | |
36 Underperform | HK$48.40M | ― | -72.35% | ― | ― | -51.39% |
Prosperity Group International Limited, listed on the Hong Kong Stock Exchange, announced a supplemental update to its annual report for the year ending June 30, 2024, focusing on the 2023 Share Option Scheme. The scheme, adopted on December 15, 2023, allows for the issuance of up to 6,678,112 shares, representing 5.34% of the company’s issued shares. The scheme is valid for 10 years, with specific limits on the number of shares that can be issued to participants within a 12-month period. As of the report date, no options have been granted under the 2023 Scheme, and the remaining life of the scheme is approximately 9 years and 5 months.